UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | H | J | L | M | S | T | V | W
Number of items: 52.

A

Aamdal, S; Lee, SM; Radford, JA; Thatcher, N; Calabresi, F; Israels, SP; Kerger, J; (1991) Sequential administration of dacarbazine and fotemustine in disseminated melanoma. In: (Proceedings) 1991 AACR Annual Meeting/82nd Annual Meeting, Houston, TX.. (pp. 191-). Proc Am Assoc Cancer Res

Abbasi, AM; Chester, KA; MacPherson, AJS; Boxer, G; Begent, RHJ; Malcolm, ADB; (1991) Comparison of messenger-RNA and protein expression for carcinoembryonic antigen(CEA)in tissue-section of normal colorectal mucosa and colonic adenocarcinoma. In: (pp. A176-A176).

B

BAGSHAWE, KD; SHARMA, SK; SOUTHALL, PJ; BODEN, JA; BOXER, GM; PATRIDGE, TA; ANTONIW, P; (1991) SELECTIVE UPTAKE OF TOXIC NUCLEOSIDE (I-125UDR) BY RESISTANT CANCER. BRIT J RADIOL , 64 (757) 37 - 44.

BAGSHAWE, KD; SHARMA, SK; SPRINGER, CJ; ANTONIW, P; BODEN, JA; ROGERS, GT; BURKE, PJ; (1991) ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - CLINICAL REPORT. In: (Proceedings) WORKSHOP ON MONOCLONAL ANTIBODIES IN BREAST AND OVARIAN CANCER. (pp. pp. 233-238). ASFRA

BAKER, SR; MICHIE, CA; SOO, KS; WYLLIE, JH; BEVERLEY, PCL; (1991) LYMPHOPENIA IN DIVERTICULITIS. LANCET , 338 (8766) 569 - 570.

Beyaert, R; De Potter, C; Vanhaesebroeck, B; Van Roy, F; Fiers, W; (1991) Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride. Am J Pathol , 138 (3) pp. 727-739.

Bower, M; Colston, KW; Stein, RC; Hedley, A; Gazet, JC; Ford, HT; Combes, RC; (1991) Topical calcipotriol treatment in advanced breast cancer. Lancet , 337 (8743) pp. 701-702.

Bower, M; Stein, RC; Hedley, A; Davenport, J; Colston, K; Coombes, RC; (1991) The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy. Cancer Chemother Pharmacol , 28 (4) pp. 311-312.

C

CALVERT, AH; (1991) COMBINING CISPLATIN AND CARBOPLATIN COMPLEMENTARY OR CONTRADICTORY. ANN ONCOL , 2 (2) 89 - 91.

CALVERT, AH; NEWELL, DR; BALMANNO, K; PEARSON, AD; PRICE, L; KIER, M; (1991) PHARMACOKINETICS OF CARBOPLATIN IN CHILDREN AND THE DEVELOPMENT OF A PEDIATRIC DOSE EQUATION. PLATINUM AND OTHER METAL COORDINATION COMPOUNDS IN CANCER CHEMOTHERAPY 335 - 343.

CALVERT, AH; URIE, J; (1991) THE COSTS OF CARBOPLATIN TREATMENT. SEMIN ONCOL , 18 (1) 28 - 31.

Cooper, DP; O'Connor, PJ; Davies, J; Thatcher, N; Lee, SM; (1991) Alkylation of lymphocyte DNA during chemotherapy with DTIC. In: (pp. 32-).

D

DAWSON, PM; BLAIR, SD; BEGENT, RHJ; KELLY, AMB; BOXER, GM; THEODOROU, NA; (1991) THE VALUE OF RADIOIMMUNOGUIDED SURGERY IN 1ST AND 2ND LOOK LAPAROTOMY FOR COLORECTAL-CANCER. DIS COLON RECTUM , 34 (3) 217 - 222.

Davis, CL; Whelan, JS; Leahy, M; MacCullum, P; Norton, AJ; Amess, JAL; Rohatiner, AZS; (1991) Intermediate dose cytosine arabinoside and etoposide for the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma. In:

E

Evans, C; Stein, RC; Davenport, J; Dougherty, L; Carruthers, L; Coombes, RC; (1991) Comparison of ondansetron with dexamethasone and domperidone in the prophylaxis of non-cisplatin chemotherapy induced emesis refractory to dexamethasone. Eur J Cancer , 27 (3) pp. 302-303.

F

FRY, AM; CHRESTA, CM; DAVIES, SM; WALKER, MC; HARRIS, AL; HARTLEY, JA; MASTERS, JRW; (1991) RELATIONSHIP BETWEEN TOPOISOMERASE-II LEVEL AND CHEMOSENSITIVITY IN HUMAN TUMOR-CELL LINES. CANCER RES , 51 (24) 6592 - 6595.

H

HARMSEN, MC; TOLNER, B; KRAM, A; GO, SJ; DEHAAN, A; WESSELS, JGH; (1991) SEQUENCES OF 3 DSRNAS ASSOCIATED WITH LA FRANCE DISEASE OF THE CULTIVATED MUSHROOM (AGARICUS-BISPORUS). CURR GENET , 20 (1-2) 137 - 144.

HOCHHAUSER, D; HARRIS, AL; (1991) DRUG-RESISTANCE. BRIT MED BULL , 47 (1) 178 - 196.

HUMM, JL; BAGSHAWE, KD; SHARMA, SK; BOXER, G; (1991) TISSUE DOSE ESTIMATES FOLLOWING THE SELECTIVE UPTAKE OF I-125UDR AND OTHER RADIOLABELED THYMIDINE PRECURSORS IN RESISTANT TUMORS. BRITISH JOURNAL OF RADIOLOGY , 64 (757) pp. 45-49.

Haynes, BP; Jarman, M; Dowsett, M; Mehta, A; Lønning, PE; Griggs, LJ; Jones, A; (1991) Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer. Cancer Chemother Pharmacol , 27 (5) pp. 367-372.

J

JACKMAN, AL; MARSHAM, PR; MORAN, RG; KIMBELL, R; OCONNOR, BM; HUGHES, LR; CALVERT, AH; (1991) THYMIDYLATE SYNTHASE INHIBITORS - THE INVITRO ACTIVITY OF A SERIES OF HETEROCYCLIC BENZOYL RING MODIFIED 2-DESAMINO-2-METHYL-N-10-SUBSTITTED-5,8-DIDEAZAFOLATES. ADV ENZYME REGUL , 31 13 - 27.

JACKMAN, AL; MARSHAM, PR; MORAN, RG; KIMBELL, R; OCONNOR, BM; HUGHES, LR; CALVERT, AH; (1991) THYMIDYLATE SYNTHASE INHIBITORS - THE INVITRO ACTIVITY OF A SERIES OF HETEROCYCLIC BENZOYL RING MODIFIED 2-DESAMINO-2-METHYL-N-10-SUBSTITTED-5,8-DIDEAZAFOLATES. ADVANCES IN ENZYME REGULATION, VOL 31 , 31 13 - 27.

JACKMAN, AL; NEWELL, DR; GIBSON, W; JODRELL, DI; TAYLOR, GA; BISHOP, JA; HUGHES, LR; (1991) THE BIOCHEMICAL PHARMACOLOGY OF THE THYMIDYLATE SYNTHASE INHIBITOR, 2-DESAMINO-2-METHYL-N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (ICI-198583). BIOCHEM PHARMACOL , 42 (10) 1885 - 1895.

JACKMAN, AL; TAYLOR, GA; GIBSON, W; KIMBELL, R; BROWN, M; CALVERT, AH; JUDSON, IR; (1991) ICI-D1694, A QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR THAT IS A POTENT INHIBITOR OF L1210 TUMOR-CELL GROWTH-INVITRO AND INVIVO - A NEW AGENT FOR CLINICAL-STUDY. CANCER RES , 51 (20) 5579 - 5586.

JACKSON, C; HARTLEY, JA; JENKINS, TC; GODFREY, R; SAUNDERS, R; THURSTON, DE; (1991) N-2,N-4,N-6-TRI(HYDROXYMETHYL)-N-2,N-4,N-6-TRIMETHYLMELAMINE (TRIMELAMOL) IS AN EFFICIENT DNA CROSS-LINKING AGENT INVITRO. BIOCHEMICAL PHARMACOLOGY , 42 (11) pp. 2091-2097. 10.1016/0006-2952(91)90343-4.

JODRELL, D; FORREST, A; HAWTOF, J; GRAHAM, M; CALVERT, AH; EGORIN, M; (1991) THE POPULATION PHARMACOKINETICS OF CI941, A NOVEL ANTHRAPYRAZOLE ANTICANCER AGENT. CLIN PHARMACOL THER , 49 (2) 195 - 195.

JODRELL, DI; NEWELL, DR; GIBSON, W; HUGHES, LR; CALVERT, AH; (1991) THE PHARMACOKINETICS OF THE QUINAZOLINE ANTIFOLATE ICI D1694 IN MICE AND RATS. CANCER CHEMOTH PHARM , 28 (5) 331 - 338.

JODRELL, DI; NEWELL, DR; MORGAN, SE; CLINTON, S; BENSTED, JPM; HUGHES, LR; CALVERT, AH; (1991) THE RENAL EFFECTS OF N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (CB3717) AND A NON-NEPHROTOXIC ANALOG ICI D1694, IN MICE. BRIT J CANCER , 64 (5) 833 - 838.

JUDSON, IR; CALVERT, AH; GORE, ME; BALMANNO, K; GUMBRELL, LA; PERREN, T; WILTSHAW, E; (1991) PHASE-II TRIAL OF TRIMELAMOL IN REFRACTORY OVARIAN-CANCER. BRIT J CANCER , 63 (2) 311 - 313.

L

LEENHOUTS, KJ; TOLNER, B; BRON, S; KOK, J; VENEMA, G; SEEGERS, JFML; (1991) NUCLEOTIDE-SEQUENCE AND CHARACTERIZATION OF THE BROAD-HOST-RANGE LACTOCOCCAL PLASMID PWVO1. PLASMID , 26 (1) 55 - 66.

Lee, SM; Fan, CY; Rafferty, JA; Potter, PM; O'Connor, PJ; Margison, GP; (1991) Anti-human 06-alkylguanine-DNA-alkyltransferase antibodies show cellular heterogeneity and predominantly nuclear staining in normal and tumour tissue. In: (Proceedings) BACR/ACP Annual Meeting, Manchester.. (pp. 64-). British Journal of Cancer

Lee, SM; Shelbourn, SL; Thatcher, N; (1991) Sequential DTIC and fotemustine in the treatment of metastatic melanoma. In: (Proceedings) ECCO 6/Sixth European Conference on Clinical Oncology, Firenze, Italy.. (pp. S160-). European Journal of Cancer

Lee, SM; Thatcher, N; Margison, GP; (1991) 06-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following DTIC and fotemustine. In: (pp. 33-).

Lee, SM; Thatcher, N; Margison, GP; (1991) 06-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine. Cancer Research , 51 (2) pp. 619-623.

Lee, SM; Thatcher, N; Margison, GP; (1991) Activity of 06-alkylguanine-DNA alkyltransferase following sequential dacarbazine (DTIC) and fotemustine. In: (Proceedings) BACR/ACP Annual Meeting, Manchester.. (pp. 49-). British Journal of Cancer

M

MARSHAM, PR; HUGHES, LR; JACKMAN, AL; HAYTER, AJ; OLDFIELD, J; WARDLEWORTH, JM; BISHOP, JAM; (1991) QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - HETEROCYCLIC BENZOYL RING MODIFICATIONS. J MED CHEM , 34 (5) 1594 - 1605.

MARSHAM, PR; JACKMAN, AL; HAYTER, AJ; DAW, MR; SNOWDEN, JL; OCONNOR, BM; BISHOP, JAM; (1991) QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - BRIDGE MODIFICATIONS AND CONFORMATIONALLY RESTRICTED ANALOGS IN THE C2-METHYL SERIES. J MED CHEM , 34 (7) 2209 - 2218.

S

SHARMA, SK; BAGSHAWE, KD; SPRINGER, CJ; BURKE, PJ; ROGERS, GT; BODEN, JA; ANTONIW, P; (1991) ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - A 3 PHASE SYSTEM. In: (Proceedings) WORKSHOP ON MONOCLONAL ANTIBODIES IN BREAST AND OVARIAN CANCER. (pp. pp. 225-231). ASFRA

SPRINGER, CJ; BAGSHAWE, KD; SHARMA, SK; SEARLE, F; BODEN, JA; ANTONIW, P; BURKE, PJ; (1991) ABLATION OF HUMAN CHORIOCARCINOMA XENOGRAFTS IN NUDE-MICE BY ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) WITH 3 NOVEL COMPOUNDS. EUROPEAN JOURNAL OF CANCER , 27 (11) pp. 1361-1366. 10.1016/0277-5379(91)90010-B.

Stein, RC; (1991) Initial studies of 4-hydroxyandrostenedione in premenopausal patients with advanced breast cancer. In: Coombes, RC and Dowsett, M, (eds.) 4-hydroxyandrostenedione: a new approach to hormone-dependent cancer. (pp. 35-39). Royal Society of Medicine

Stein, RC; Cannon, S; Cassoni, A; Pringle, JS; Stoker, DJ; Souhami, RL; (1991) Clinical oncology: case presentations from oncology centres. 1. Ewing's sarcoma. The London Bone Tumour Service. Eur J Cancer , 27 (11) pp. 1525-1533.

Stein, RC; Malkovska, V; Morgan, S; Galazka, A; Aniszewski, C; Roy, SE; Shearer, RJ; (1991) The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]. Br J Cancer , 63 (2) pp. 275-278.

Suffys, P; Beyaert, R; De Valck, D; Vanhaesebroeck, B; Van Roy, F; Fiers, W; (1991) Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. Eur J Biochem , 195 (2) pp. 465-475.

T

TALBOT, DC; SMITH, IE; MANSI, JL; JUDSON, I; CALVERT, AH; ASHLEY, SE; (1991) ANTHRAPYRAZOLE CI941 - A HIGHLY-ACTIVE NEW AGENT IN THE TREATMENT OF ADVANCED BREAST-CANCER. J CLIN ONCOL , 9 (12) 2141 - 2147.

THORNTON, TJ; JONES, TR; JACKMAN, AL; FLINN, A; OCONNOR, BM; WARNER, P; CALVERT, AH; (1991) QUINAZOLINE ANTIFOLATES INHIBITING THYMIDYLATE SYNTHASE - 4-THIO-SUBSTITUTED ANALOGS. J MED CHEM , 34 (3) 978 - 984.

V

VYAKARNAM, A; MATEAR, PM; CRANENBURG, C; MICHIE, C; BEVERLEY, PCL; WAHREN, B; GILL, SK; (1991) T-CELL RESPONSES TO PEPTIDES COVERING THE GAG P24 REGION OF HIV-1 OCCUR IN HIV-1 SERONEGATIVE INDIVIDUALS. INT IMMUNOL , 3 (10) 939 - 947.

Vanhaesebroeck, B; Mareel, M; Van Roy, F; Grooten, J; Fiers, W; (1991) Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo. Cancer Res , 51 (8) pp. 2229-2238.

Vanhaesebroeck, B; Van Bladel, S; Lenaerts, A; Suffys, P; Beyaert, R; Lucas, R; Van Roy, F; (1991) Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line. Cancer Res , 51 (9) pp. 2469-2477.

W

WHITE, LA; NOBLES, JA; LEE, M; HARTLEY, JA; (1991) SYNTHESIS OF AN AMIDINE LINKED ANALOG OF DISTAMYCIN-A AND ITS DNA-BINDING PROPERTIES. In: (pp. 77-ORGN). AMER CHEMICAL SOC

Whelan, JS; Davis, CL; Rule, S; Ranson, M; Smith, O; Mehta, AB; Catovsky, D; (1991) Fludarabine phosphate for the treatment of low grade lymphoid malignancy. British Journal of Cancer , 64 pp. 120-123.

Whelan, JS; Phear, GA; Rohatiner, AZS; Lister, TA; Meuth, M; (1991) DNA sequence determination of CTP synthetase mutations in ara C-resistant hamster cells. In:

Whelan, JS; Reznek, RH; Daniell, SJN; Norton, AJ; Lister, TA; Rohatiner, AZS; (1991) Computed tomography and ultrasound-guided core biopsy in the management of non-Hodgkin's lymphoma. British Journal of Cancer , 63 pp. 460-462.

This list was generated on Sun Jun 25 02:56:17 2017 BST.